SU1198786A1 - Method of diagnosis of infantile cerebral paralysis - Google Patents

Method of diagnosis of infantile cerebral paralysis Download PDF

Info

Publication number
SU1198786A1
SU1198786A1 SU843708952A SU3708952A SU1198786A1 SU 1198786 A1 SU1198786 A1 SU 1198786A1 SU 843708952 A SU843708952 A SU 843708952A SU 3708952 A SU3708952 A SU 3708952A SU 1198786 A1 SU1198786 A1 SU 1198786A1
Authority
SU
USSR - Soviet Union
Prior art keywords
dopamine
diagnosis
dopa
etiology
patient
Prior art date
Application number
SU843708952A
Other languages
Russian (ru)
Inventor
V N Vasilev
L M Shoshina
V Z Gorkin
V S Chugunov
Original Assignee
Klinicheskaya Sp Bolnitsa N 8
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinicheskaya Sp Bolnitsa N 8 filed Critical Klinicheskaya Sp Bolnitsa N 8
Priority to SU843708952A priority Critical patent/SU1198786A1/en
Application granted granted Critical
Publication of SU1198786A1 publication Critical patent/SU1198786A1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Description

Изобретение относится к области медицины, конкретно к способам диагностики детских неврологических заболеваний.The invention relates to the field of medicine, specifically to methods of diagnosis of childhood neurological diseases.

Целью изобретения является выявление параличей дофаминовой этиологии.The aim of the invention is the detection of paralysis of dopamine etiology.

Изобретение поясняется следующим примером.The invention is illustrated by the following example.

У больного К. анализ мочи проводили в четырех временных интервалах: с 9 до 12ч, с 12 до 16ч, с 16 до 20 ч и в ночь с 20 до 9 ч следующего дня.Patient K. urine analysis was performed in four time intervals: from 9 to 12 h, from 12 to 16 h, from 16 to 20 h and in the night from 20 to 9 h the next day.

86 186 1

Определяли фиуорометрнчески содержание в порционной моче дофомина:The content of dofomine in portion urine was determined fiuometrically:

0, 80, 48 и 39,2 нг/мин. и ДОФА: 0,0, 80, 48 and 39.2 ng / min. and DOPA: 0,

5, 6, 0 и 0 нг/мин.5, 6, 0 and 0 ng / min.

Затем пациенту на следующий день перорально вводили в 9 утра 0,1 г ДОФА и опять в порционной моче фпуорометрически определяли содержание дофамина: 190; 172; 200 и 114 нг/мин, и ДОФА: 126, 106, 41 и 45 нг/мин.Then, the next day, the patient was orally administered at 9 am with 0.1 g of DOPA, and again in portion urine, the content of dopamine was determined porporemetrically: 190; 172; 200 and 114 ng / min, and DOPA: 126, 106, 41 and 45 ng / min.

чh

На этом основании у больного диагностирован детский церебральный паралич дофаминовой этиологии.On this basis, the patient was diagnosed with cerebral palsy of dopamine etiology.

Claims (1)

СПОСОБ ДИАГНОСТИКИ ШОШИНОЙ-ВАСИЛЬЕВА ДЕТСКОГО ЦЕРЕБРАЛЬНОГО ПАРАЛИЧА путем биохимического исследования мочи.о т л и ч а ю щ и й с я тем,что, с целью выявления параличей дофаминовой этиологии, в порционной моче пациента определяют содержание ДОФА и дофамина, затем больному вводят перорально ДОФА и в порционной моче повторно определяют содержание ДОФА и дофамина и при увеличении их концентраций относительно исходного уровня диагносцируют церебральный паралич дофаминовой этиологии.METHOD OF DIAGNOSIS Shoshina-VASILYEVA cerebral palsy by biochemical studies mochi.o t l and h and w and d w i with the fact that, in order to detect dopamine paralysis etiology, batch patient urine determined Dopa and dopamine contents, then the patient is administered orally DOPA and in portion urine re-determine the content of DOPA and dopamine and, with an increase in their concentrations relative to the initial level, diagnose cerebral palsy of dopamine etiology. 11987861198786 I)I)
SU843708952A 1984-03-21 1984-03-21 Method of diagnosis of infantile cerebral paralysis SU1198786A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU843708952A SU1198786A1 (en) 1984-03-21 1984-03-21 Method of diagnosis of infantile cerebral paralysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU843708952A SU1198786A1 (en) 1984-03-21 1984-03-21 Method of diagnosis of infantile cerebral paralysis

Publications (1)

Publication Number Publication Date
SU1198786A1 true SU1198786A1 (en) 1986-06-15

Family

ID=21106682

Family Applications (1)

Application Number Title Priority Date Filing Date
SU843708952A SU1198786A1 (en) 1984-03-21 1984-03-21 Method of diagnosis of infantile cerebral paralysis

Country Status (1)

Country Link
SU (1) SU1198786A1 (en)

Similar Documents

Publication Publication Date Title
Mustafa et al. Cerebrospinal Fluid Prostaglandins, Interleukin 1β, and Tumor Necrosis Factor in Bacterial Meningitis: Clinical and Laboratory Correlations in Placebo-Treated and Dexamethasone-Treated Patients
AU5265393A (en) Method of detecting neurological disease or dysfunction
PT91590A (en) METHOD FOR ANALYZING BIOPOLIMEROS BY HYDRIDACAO IN SITU
Azen Properties of salivary basic proteins showing polymorphism
Rapoport et al. Effect of corticotropin (ACTH) on children with the nephrotic syndrome
SU1198786A1 (en) Method of diagnosis of infantile cerebral paralysis
Macfarlane et al. Single injection treatment of meningococcal meningitis 1. Long-acting penicillin
Rowland et al. Myoglobin and muscular dystrophy: Electrophoretic and immunochemical study
Whitehead et al. Metabolites of phenylalanine in the urine of children with kwashiorkor
FR2357899A1 (en) PROCESS FOR PURIFICATION OF AN ANTISERUM GENERATED AGAINST AN ENZYME-INHIBITOR COMPLEX FORMING PART OF THE BLOOD COAGULATION SYSTEM OR OF THE FIBRINOLYTIC SYSTEM ACTIVE IN BLOOD PLASMA
Peter et al. Oxidative phosphorylation and calcium transport by sarcotubular vesicles in myotonic dystrophy
Bouloukos et al. Immunoglobulins in cerebrospinal fluid in various neurologic disorders.
SU1210789A1 (en) Method of diagnosis of functional disturbance of gastric secretion
SU1462194A1 (en) Method of differential analysis of ulcerous desease of duodenum and lingering cholecystitis
SU1585707A1 (en) Method of diagnosis of t-immunodeficiency
SU1698778A1 (en) Method for prognostication coarse of acute respiratory disease for children of early age
SU1698764A1 (en) Method for determining persons, predisposed to respiratory tract diseases
SU1720014A1 (en) Method of estimation of stomach hyperacid state
SU1663546A1 (en) Method for diagnostication of increased sensitivity of auditory system to otopathogenic effects
SU1355931A1 (en) Method of determining individual sensitivity to rehydration therapy in case of patients having intestinal infection
SU787995A1 (en) Method of differentiating t- and b-lymphocytes of a man
SU1691748A1 (en) Method of differential diagnosis of ureolithiasis and lithiasis
SU1471132A1 (en) Method of diagnosing active phase of rneumatic diseases
Anil et al. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis
SU1569710A1 (en) Method of radio immunological determination of testosterone in manъs blood serum